T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trialKatie Ewer, Megan Baker, Amy Flaxman et al.|Nature Medicine|2020Cited by 643
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responsesJordan R. Barrett, Catherine Green, Sandra Belij‐Rammerstorfer et al.|Nature Medicine|2020Cited by 340
Processes of Care, Illness Severity, and Outcomes in the Management of Community-Acquired Pneumonia at Academic HospitalsJulien Dedier, Steven J. Atlas, Daniel E. Singer et al.|Archives of Internal Medicine|2001Cited by 113